600 patients66,869 observations120 daysLIVE

Patient P-01483

Synthetic patientNBL-101 · Day 109 · 45–54 · M · baseline S14Open companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Declining
Discontinuation risk
27%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 72 AD-05 recommendedAdherence Support AD-05
  3. Day 73 Patient acceptedStarted AD-05 in the companion
  4. Day 78 No meaningful changeAdherence Support AD-05
  5. Day 89 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 89.

Primary contributors, last 14 days
  • Treatment adherence-9
  • Toxicity-8
  • Inflammatory activity-5
  • Nutritional resilience-5

What helped?

  • Adherence Support AD-05Day 72
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
  • Autonomic recovery 20
    • WearableShort sleep window
  • Mucosal barrier integrity 10
    • WearableSleep 5.3 h, below personal baseline
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 4.4 · butyrate capacity 48/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
57 ms
Sleep
5.8 h
Steps
4,833
Resting HR
63 bpm
Daily log: GI score 21, nutritional resilience 63, adherence 80.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0154154%S09AD-05no change43
P-0131353%S01BR-03improved32
P-0137752%S11AD-05no change42
P-0182950%S1131
P-0141549%S1232
P-0137048%S0344
P-0181647%S0135
P-0184647%S0137
P-0184747%S0137
P-0160146%S0340
P-0171946%S1141
P-0172245%S0936